Top Sell
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Carl Zeiss Meditec AG | 2 | 1 | 0 | 0 | €97.95 | €101.00 | 3.114% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.73 | €18.30 | 957.572% |
| Accelerate Diagnostics Inc. | 1 | 1 | 0 | 0 | €0.86 | - | - |
| T2 Biosystems Inc. | 0 | 12 | 0 | 0 | €0.16 | - | - |
| Immuron | 0 | 1 | 0 | 1 | €2.16 | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.39 | - | - |
| Medigene AG | 0 | 2 | 0 | 0 | €1.54 | €1.00 | -35.065% |
| Arca Biopharma | 0 | 22 | 0 | 3 | €3.26 | - | - |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Sangamo Therapeutics Inc. | 11 | 13 | 0 | 1 | €0.49 | €2.79 | 474.168% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 1 | €1.07 | €2.00 | 86.480% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €0.95 | - | - |
| Ryman Healthcare Group Ltd. | 1 | 1 | 0 | 0 | €2.17 | - | - |
| Merck KGaA | 3 | 1 | 0 | 0 | €153.40 | €146.00 | -4.824% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| InVivo Therapeutics Holdings | 1 | 17 | 0 | 0 | €0.31 | €1.60 | 416.129% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Vaxart Inc. | 1 | 1 | 1 | 1 | €0.69 | - | - |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.22 | €26.71 | 118.705% |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| SI-BONE Inc | 15 | 1 | 1 | 1 | €13.30 | €23.59 | 77.367% |
| Omnicell Inc. | 3 | 2 | 1 | 0 | €25.20 | €35.45 | 40.690% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.89 | €67.64 | 65.437% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |